Notes / Company

Alembic Pharmaceuticals Ltd.

APLLTD BSE 533573 ISIN INE901L01018 Pharmaceuticals

Fundamentals

Market cap: ₹14,854 cr
P/E: 23.19×
ROE: 11.24%
Debt / equity: 0.23
Div yield: 1.59%
52-week range: 635.80 — 1107.90

Research on Tijori Finance

The timeline — 1 note on Alembic Pharmaceuticals Ltd.

May 2026

21 May 26 · 15:31 IST Brief

Brief · Earnings

Alembic sets FY27 revenue growth target at low double digits

Q4 FY26 conference call transcript confirms guidance for low double-digit revenue growth, R&D spend of ₹750-800 crore, and margin improvement.

Verify on exchange BSE filings for APLLTD NSE filings for APLLTD Tijori Finance company page